BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-04-30

Reporting Person: Mueller Brian (EVP, Chief Financial Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-30	Common Stock	A	341	$62.407	Acquired	31357	Direct
2021-05-07	Common Stock	M	6709	$28.23	Acquired	38066	Direct
2021-05-07	Common Stock	S	6709	$79.50	Disposed	31357	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-07	Stock Option (Right to buy Common Stock)	$28.23	M	6709	Disposed	2021-05-30	Common Stock (6709)	Direct

F1: Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.

F2: Trade made pursuant to a 10b5-1 plan executed on January 29, 2021.

F3: Reflects the number of options outstanding after the transactions from this specific stock option grant.